N. Gilchrist

发表

The effect of the Oxford uncemented medial compartment arthroplasty on the bone mineral density and content of the proximal tibia.

C. Frampton, G. Hooper, R. Maxwell, 2013, The bone & joint journal.

Osteoporotic Vertebral Fracture Prevalence Varies Widely

J. Quayle, N. Gilchrist, G. Hamilton, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group.

P. Sambrook, J. Rodriguez-Portales, G. Fuleihan, 2000, The Journal of clinical endocrinology and metabolism.

Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial

J. Eisman, M. McClung, P. Ravn, 1998, Annals of Internal Medicine.

Alendronate prevents bone loss in patients with acute spinal cord injury: a randomized, double-blind, placebo-controlled study.

C. Frampton, M. Nicholls, C. Frampton, 2007, The Journal of clinical endocrinology and metabolism.

Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial.

S. Cummings, M. Bhandari, S. Boonen, 2012, The Journal of bone and joint surgery. American volume.

Randomized, active-controlled study of once-weekly alendronate 280 mg high dose oral buffered solution for treatment of Paget’s disease

I. Reid, D. Hosking, P. Selby, 2008, Osteoporosis International.

Failure ofconventional chemotherapy inaggressive lymphomas

D. Cunningham, I. L. Evans, N. Gilchrist, 1987 .

Failure of conventional chemotherapy in aggressive lymphomas.

D. Cunningham, I. L. Evans, N. Gilchrist, 1987, Postgraduate medical journal.

The hemorheological effects of raloxifene in postmenopausal women with osteoporosis. Results of a 3-year placebo-controlled clinical trial.

T. Blackwell, B. Shand, N. Gilchrist, 2002, Clinical hemorheology and microcirculation.

A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates

M. McClung, J. McGinnis, A. Santora, 2015, Osteoporosis International.

Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region

I. Reid, A. Mithal, P. Ebeling, 2021, Osteoporosis International.

Erythrocyte sedimentation rates in the elderly: a community study.

H. C. Hanger, R. Sainsbury, N. Gilchrist, 1991, The New Zealand medical journal.

Atypical subtrochanteric fractures, bisphosphonates, blinded radiological review

G. Hooper, C. Frampton, M. Coates, 2012, ANZ journal of surgery.

IQ driving QI: the Asia Pacific Consortium on Osteoporosis (APCO): an innovative and collaborative initiative to improve osteoporosis care in the Asia Pacific

P. Ebeling, S. Bhadada, M. Chandran, 2020, Osteoporosis International.

Cough with ACE Inhibitors: A Bigger Problem in Some Racial Groups?

M. Nicholls, N. Gilchrist, 2005, Cardiovascular Drugs and Therapy.

Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone

S. Lewis, M. Boers, G. Murray, 2019, BMJ Open.

Zoledronate in the prevention of Paget(cid:146)s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1 mediated Paget(cid:146)s disease of bone

S. Lewis, M. Boers, S. Ralston, 2019 .

Measurement of bone density around the Oxford medial compartment knee replacement using iDXA. A precision study.

C. Frampton, G. Hooper, R. Maxwell, 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

EFFECT OF OPIATE, GENERAL ANAESTHESIA AND SURGERY ON PLASMA ATRIAL NATRIURETIC PEPTIDE LEVELS IN MAN

E. Espiner, M. Nicholls, T. Yandle, 1987 .

Chemotherapy in advanced gastric cancer.

C. McArdle, D. Cunningham, D. Carter, 1985, Cancer treatment reports.

Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.

C. McArdle, D. Cunningham, G. Forrest, 1985, British medical journal.

Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma

D. Cunningham, I. Watson, W. Fitch, 2004, Cancer Chemotherapy and Pharmacology.

Osteoporosis follow-up after fracture.

T. Wilkinson, R. Sainsbury, N. Gilchrist, 2001, Archives of internal medicine.

A randomized, double-masked comparison of the antihypertensive efficacy and safety of combination therapy with losartan and hydrochlorothiazide versus captopril and hydrochlorothiazide in elderly and younger patients

J. Critchley, C. Sweet, N. Gilchrist, 1996 .

The effects of a high calcium dairy food on bone health in pre-pubertal children in New Zealand.

C. Wall, C. Frampton, N. Gilchrist, 2004, Asia Pacific journal of clinical nutrition.

Memantine and functional communication in Alzheimer's disease: results of a 12-week, international, randomized clinical trial.

R. Hofbauer, J. Saxton, M. Woodward, 2012, Journal of Alzheimer's disease : JAD.

Production, composition and toxicology studies of Enzogenol® Pinus radiata bark extract.

A. Pipingas, M. Frevel, W. Grigsby, 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Onycholysis associated with cytotoxic drugs.

D. Cunningham, G. Forrest, N. Gilchrist, 1985, British medical journal.

A clinical and pharmacokinetic phase I study of 1,2,4-triglycidylurazol (TGU, NSC 332488).

D. Cunningham, S. Kaye, J. Stuart, 1986, European journal of cancer & clinical oncology.

Alfacalcidol as a modulator of growth of low grade non-Hodgkin's lymphomas.

C. McArdle, R. Cowan, D. Cunningham, 1985, British medical journal.

Influence of polysorbate 80 (Tween 80) and etoposide (VP-16-213) on the pharmacokinetics and urinary excretion of adriamycin and its metabolites in cancer patients

D. Cunningham, J. Cummings, G. Forrest, 2004, Cancer Chemotherapy and Pharmacology.

Points: Cough and angiotensin converting enzyme inhibition

N. Gilchrist, 1988 .

Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo‐Controlled FREEDOM Trial and Its Extension

Jacques P. Brown, S. Cummings, R. Eastell, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort

S. Lewis, S. Ralston, M. Brandi, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Characteristics of early Paget's disease in SQSTMI mutation carriers: baseline analysis of the ZIPP study cohort. Bone and Mineral Research.

S. Lewis, S. Ralston, M. Brandi, 2020 .

Experience of a systematic approach to care and prevention of fragility fractures in New Zealand

J. Magaziner, N. Kerse, K. Åkesson, 2022, Archives of Osteoporosis.

T-cell lymphoblastic lymphoma of the uterus complicated by Chlamydia trachomatis pneumonia.

D. Cunningham, G. Forrest, N. Gilchrist, 1986, Postgraduate medical journal.

Older patients with hip fractures: evaluation of a long-term specialist orthopaedic medicine service in their outcomes.

J. Thwaites, R. Sainsbury, N. Gilchrist, 2007, The New Zealand medical journal.

Discontinuation of Denosumab and Associated Fracture Incidence: Analysis From the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial

Jacques P. Brown, A. Grauer, C. Roux, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group

J. Bilezikian, P. Miller, P. Ebeling, 2019, Osteoporosis International.

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study

N. Binkley, H. Resch, A. Lombardi, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Shared care between geriatricians and orthopaedic surgeons as a model of care for older patients with hip fractures.

A. Rothwell, J. Thwaites, R. Sainsbury, 2005, The New Zealand medical journal.

Hip fracture mortality and morbidity--can we do better?

T. Wilkinson, M. Merrilees, N. Gilchrist, 2001, The New Zealand medical journal.

Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial

S. Boonen, M. Nevitt, D. Revicki, 2012, Osteoporosis International.

The added effectiveness of early geriatrician involvement on acute orthopaedic wards to orthogeriatric rehabilitation.

T. Wilkinson, H. C. Hanger, R. Sainsbury, 1996, The New Zealand medical journal.

Enhanced hip fracture management: use of statistical methods and dataset to evaluate a fractured neck of femur fast track pathway-pilot study.

Ma Yi, K. Dalzell, G. Hooper, 2017, The New Zealand medical journal.

Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial

M. Bhandari, B. Mitlak, R. Burge, 2016, Clinical orthopaedics and related research.